During the recent session, Impact BioMedical Inc (AMEX:IBO)’s traded shares were 1.94 million. At the last check today, the stock’s price was $2.51, reflecting an intraday gain of 14.21% or $0.31. The 52-week high for the IBO share is $6.17, that puts it down -145.82 from that peak though still a striking 79.68% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $28.89M, and the average intraday trading volume over the past 10 days was 18.47 million shares, and the average trade volume was 3.10 million shares over the past three months.

Impact BioMedical Inc (AMEX:IBO) trade information

Impact BioMedical Inc (IBO) registered a 14.21% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 14.21% in intraday trading to $2.51, hitting a weekly high. The stock’s 5-day price performance is 20.80%, and it has moved by 32.24% in 30 days. The short interest in Impact BioMedical Inc (AMEX:IBO) is 9001.0 shares and it means that shorts have 0.3 day(s) to cover.

IBO Dividends

Impact BioMedical Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Impact BioMedical Inc (AMEX:IBO)’s Major holders

Impact BioMedical Inc insiders own 55.16% of total outstanding shares while institutional holders control 1.89%, with the float percentage being 4.22%.

Also, the Mutual Funds coming in first place with the largest holdings of Impact BioMedical Inc (IBO) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 94.02 shares. This amounts to just over 0.00 percent of the company’s overall shares, with a $0.22 million market value. The same data shows that the other fund manager holds slightly less at 31.61, or about 0.00% of the stock, which is worth about $75253.0.